Lyra Therapeutics, Inc. (LYRA)
0.80
+0.10
(+14.29%)
USD |
OTCM |
Jun 09, 16:00
Lyra Therapeutics Total Liabilities (Quarterly) : 46.82M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.23M |
| CorMedix, Inc. | 378.59M |
| Eloxx Pharmaceuticals, Inc. | 16.09M |
| Cannabis Global, Inc. | 6.178M |
| BioStem Technologies, Inc. | 23.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.11M |
| Shareholders Equity (Quarterly) | -10.72M |
| Debt to Equity Ratio | -2.824 |
| Current Ratio | 1.709 |
| Net Debt Paydown Yield | 24.82% |